Correlation Between Exagen and Legend Biotech
Can any of the company-specific risk be diversified away by investing in both Exagen and Legend Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exagen and Legend Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exagen Inc and Legend Biotech Corp, you can compare the effects of market volatilities on Exagen and Legend Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exagen with a short position of Legend Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exagen and Legend Biotech.
Diversification Opportunities for Exagen and Legend Biotech
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Exagen and Legend is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Exagen Inc and Legend Biotech Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Legend Biotech Corp and Exagen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exagen Inc are associated (or correlated) with Legend Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Legend Biotech Corp has no effect on the direction of Exagen i.e., Exagen and Legend Biotech go up and down completely randomly.
Pair Corralation between Exagen and Legend Biotech
Considering the 90-day investment horizon Exagen Inc is expected to generate 1.95 times more return on investment than Legend Biotech. However, Exagen is 1.95 times more volatile than Legend Biotech Corp. It trades about 0.06 of its potential returns per unit of risk. Legend Biotech Corp is currently generating about -0.06 per unit of risk. If you would invest 197.00 in Exagen Inc on October 5, 2024 and sell it today you would earn a total of 161.00 from holding Exagen Inc or generate 81.73% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Exagen Inc vs. Legend Biotech Corp
Performance |
Timeline |
Exagen Inc |
Legend Biotech Corp |
Exagen and Legend Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Exagen and Legend Biotech
The main advantage of trading using opposite Exagen and Legend Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exagen position performs unexpectedly, Legend Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legend Biotech will offset losses from the drop in Legend Biotech's long position.Exagen vs. Fonar | Exagen vs. Burning Rock Biotech | Exagen vs. Sera Prognostics | Exagen vs. Castle Biosciences |
Legend Biotech vs. Vaxcyte | Legend Biotech vs. Apellis Pharmaceuticals | Legend Biotech vs. Travere Therapeutics | Legend Biotech vs. Akero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |